GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

IMAT-ITCR Collaboration: Multiplexed Spatial Data calibration and analysis using micro-capsules

$84,750
Hanspeter Pfister · Harvard Medical School · U01 · FY2024 · CA

IMAT-ITCR Collaboration: Multiplexed Spatial Data Calibration and analysis using micro-capsules

$84,716
Allon Moshe Klein · Harvard Medical School · R33 · FY2024 · CA

Immune Regulation of Disseminated Cancer Cell Dormancy

$84,709
Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R03 · FY2021 · CA

Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis

$84,698
Alfred Ayala · Rhode Island Hospital · R35 · FY2023 · GM

Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming

$84,638
Samuel G Katz · Yale University · R21 · FY2024 · CA

Uncovering actionable signaling pathways required for solid tumor brain metastasis

$84,435
Jacob Peter Hoj · Duke University · K00 · FY2021 · CA

INTERACTION OF YEAST CHECKPOINT PROTEINS AS DRUG ASSAY

$84,315
Emory University · R01 · FY2001 · CA

In vivo imaging of mitochondria structure and function in therapy resistant lung tumors

$84,314
David B Shackelford · University Of California Los Angeles · R01 · FY2025 · CA

INTERACTION OF YEAST CHECKPOINT PROTEINS AS DRUG ASSAY

$84,269
University Of North Texas Hlth Sci Ctr · R01 · FY2003 · CA

INTERACTION OF YEAST CHECKPOINT PROTEINS AS DRUG ASSAY

$84,269
University Of North Texas Hlth Sci Ctr · R01 · FY2004 · CA

Risk Assessment and Outcomes Across the Clinical Spectrum of Cardiotoxicity from Immune Checkpoint Inhibitors

$83,932
Evaline Cheng · Stanford University · F32 · FY2024 · HL

Development of Preventive Strategies and Therapy for HIV Infection

$83,925
Robert Yarchoan · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Development of Preventive Strategies and Therapy for HIV Infection

$83,905
Robert Yarchoan · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA

Acute Kidney Injury with Immune Checkpoint Inhibitors and Beta-Lactam Antibiotics

$83,884
Haedi Thelen · University Of Pennsylvania · F32 · FY2024 · DK

TGX-1214 - Combination strategy for the treatment of advanced pancreatic cancer

$83,743
Gerardo Guillermo Mackenzie · University Of California At Davis · R01 · FY2024 · CA

GI RESTRICTION POINT &TCR ACTIVATION INDUCED APOPTOSIS

$83,419
Washington University · K08 · FY2000 · CA

Targeting Wnt signaling in therapy-resistant ovarian cancer

$83,270
Benjamin G Bitler · University Of Colorado Denver · R37 · FY2025 · CA

Tumor Immunology and Immunotherapy (TII)

$83,267
Antoni Ribas · University Of California Los Angeles · P30 · FY2025 · CA

Radiobiology and Imaging Program

$83,257
Amit Maity · University Of Pennsylvania · P30 · FY2023 · CA

Radiobiology and Imaging Program

$83,256
Terence P Gade · University Of Pennsylvania · P30 · FY2024 · CA

Radiobiology and Imaging Program

$83,107
Amit Maity · University Of Pennsylvania · P30 · FY2021 · CA

Project 1: Targeting the Neutrophil Lineage To Enhance Immune Checkpoint Inhibitor Efficacy in NSCLC

$82,973
A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2021 · CA

Targeting Chronic ER Stress in T Cells to Improve Cancer Immunotherapy

$82,870
Jessica E Thaxton · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Chemotherapy and the Bladder Cancer Immune Microenvironment

$82,863
William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma

$82,478
Michael Daniel Green · University Of Michigan At Ann Arbor · R01 · FY2024 · CA